These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 16688597

  • 1. Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients.
    Rota E, Bellone G, Rocca P, Bergamasco B, Emanuelli G, Ferrero P.
    Neurol Sci; 2006 Apr; 27(1):33-9. PubMed ID: 16688597
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.
    Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Bouwman F, Venturelli E, Guidi I, Blankenstein MA, Bresolin N, Scarpini E.
    Arch Neurol; 2006 Apr; 63(4):538-43. PubMed ID: 16606766
    [Abstract] [Full Text] [Related]

  • 4. Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease.
    Zetterberg H, Andreasen N, Blennow K.
    Neurosci Lett; 2004 Sep 02; 367(2):194-6. PubMed ID: 15331151
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor and transforming growth factor-beta1 are highly expressed in the cerebrospinal fluid of premature infants with posthemorrhagic hydrocephalus.
    Heep A, Stoffel-Wagner B, Bartmann P, Benseler S, Schaller C, Groneck P, Obladen M, Felderhoff-Mueser U.
    Pediatr Res; 2004 Nov 02; 56(5):768-74. PubMed ID: 15319463
    [Abstract] [Full Text] [Related]

  • 8. Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease.
    Popp J, Bacher M, Kölsch H, Noelker C, Deuster O, Dodel R, Jessen F.
    J Psychiatr Res; 2009 May 02; 43(8):749-53. PubMed ID: 19038405
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.
    Laske C, Stransky E, Leyhe T, Eschweiler GW, Maetzler W, Wittorf A, Soekadar S, Richartz E, Koehler N, Bartels M, Buchkremer G, Schott K.
    J Psychiatr Res; 2007 Aug 02; 41(5):387-94. PubMed ID: 16554070
    [Abstract] [Full Text] [Related]

  • 11. Circulating interleukin-10 and interleukin-12 in Parkinson's disease.
    Rentzos M, Nikolaou C, Andreadou E, Paraskevas GP, Rombos A, Zoga M, Tsoutsou A, Boufidou F, Kapaki E, Vassilopoulos D.
    Acta Neurol Scand; 2009 May 02; 119(5):332-7. PubMed ID: 18976327
    [Abstract] [Full Text] [Related]

  • 12. Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression.
    Motta M, Imbesi R, Di Rosa M, Stivala F, Malaguarnera L.
    Immunol Lett; 2007 Nov 30; 114(1):46-51. PubMed ID: 17949824
    [Abstract] [Full Text] [Related]

  • 13. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid.
    Vawter MP, Dillon-Carter O, Tourtellotte WW, Carvey P, Freed WJ.
    Exp Neurol; 1996 Dec 30; 142(2):313-22. PubMed ID: 8934562
    [Abstract] [Full Text] [Related]

  • 14. In vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis.
    Katagiri K, Arakawa S, Hatano Y.
    Arch Dermatol Res; 2007 Jan 30; 298(8):397-401. PubMed ID: 17021766
    [Abstract] [Full Text] [Related]

  • 15. Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease.
    Lindberg C, Chromek M, Ahrengart L, Brauner A, Schultzberg M, Garlind A.
    Neurochem Int; 2005 Jun 30; 46(7):551-7. PubMed ID: 15843049
    [Abstract] [Full Text] [Related]

  • 16. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
    Ohrfelt A, Grognet P, Andreasen N, Wallin A, Vanmechelen E, Blennow K, Zetterberg H.
    Neurosci Lett; 2009 Feb 06; 450(3):332-5. PubMed ID: 19022350
    [Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
    Parnetti L, Tiraboschi P, Lanari A, Peducci M, Padiglioni C, D'Amore C, Pierguidi L, Tambasco N, Rossi A, Calabresi P.
    Biol Psychiatry; 2008 Nov 15; 64(10):850-5. PubMed ID: 18395699
    [Abstract] [Full Text] [Related]

  • 18. Cytokines in Alzheimer's disease and vascular dementia.
    Angelopoulos P, Agouridaki H, Vaiopoulos H, Siskou E, Doutsou K, Costa V, Baloyiannis SI.
    Int J Neurosci; 2008 Dec 15; 118(12):1659-72. PubMed ID: 18937113
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
    Rentzos M, Zoga M, Paraskevas GP, Kapaki E, Rombos A, Nikolaou C, Tsoutsou A, Vassilopoulos D.
    J Geriatr Psychiatry Neurol; 2006 Jun 15; 19(2):114-7. PubMed ID: 16690997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.